Pharmafile Logo
Pharmafocus logo
Advanced Search

Featured market report: Cancer diagnostics market – Forecast to 2020

September 22, 2015
Manufacturing and Production, Sales and Marketing cancer diagnostics, market report, marketsandmarkets

The global cancer diagnostics market is witnessing a rapid transformation owing to several technological advancements in diagnostic platforms.Moreover, the market …

Feature
Shire

Shire ADHD treatment Intuniv gets EU approval

September 21, 2015
Sales and Marketing ADHD, Shire, attention deficit hyperactivity disorder, intuniv

The European Commission has granted marketing authorisation for Shire’s Intuniv for the treatment of ADHD in children.  Intuniv (guanfacine hydrochloride prolonged …

News
Klaus Henning Jensen

Working Life: Novo Nordisk’s Klaus Henning-Jensen

September 21, 2015
Sales and Marketing Novo Nordisk, Working Life

How did you find your way into your current role?I started out in medicine at Bispebjerg, which is a large …

Feature
Amgen image

Amgen’s Kyprolis gets accelerated FDA review for expanded labelling

September 21, 2015
Sales and Marketing Amgen, FDA, Kyprolis, carfilzomib, multiple myeloma

The FDA has accepted for priority review Amgen’s supplemental new drug application for Kyprolis (carfilzomib) for patients with relapsed multiple …

News
Esbriet

Roche to present new Esbriet data at ERS Congress 2015

September 21, 2015
Research and Development, Sales and Marketing Esbriet, European Respiratory Congress, Roche, idiopathic pulmonary fibrosis, pirfenidone

Roche has announced it will present new data analyses of Esbriet in idiopathic pulmonary fibrosis (IPF) at the European Respiratory …

News
Jardiance

More positive CV data for Boehringer and Lilly’s Jardiance

September 21, 2015
Research and Development, Sales and Marketing Boehringer Ingelheim, EASD, Eli Lilly, cardiovascular risk, empagliflozin, jardiance, mortality risk, type 2 diabetes

Jardiance, an anti-diabetes drug produced by Boehringer Ingelheim and Eli Lilly, reduces the risk of death in people with type …

News

Biocair opens new site in Belgium

September 21, 2015
Research and Development, Sales and Marketing Biocair

Biocair is pleased to announce the opening of its new premises in Belgium. The new state of the art facility …

News
Press release

FDA grants Opdivo breakthrough status for kidney cancer

September 18, 2015
Research and Development, Sales and Marketing BMS, Breakthrough Therapy Designation, Bristol-Myers Squibb, FDA, Kidney cancer, immuno-oncology, immunotherapy, nivolumab, opdivo, renal cell carcinoma

The FDA has given Bristol-Myers Squibb’s immuno-oncology drug Opdivo Breakthrough Therapy Designation as a kidney cancer treatment. The FDA’s decision …

News
andygriggphoto

Bedrock Healthcare communications appoints new head of med comms

September 18, 2015
Medical Communications Andy Grigg, Bedrock

Andy Grigg has joined Bedrock Healthcare Communications as head of medical communications.  Grigg joins from Inspired Science where he was practice …

Appointment
digital cloud

Report identifies digital trends in life sciences industry

September 18, 2015
Medical Communications digital, disruptive innovations, disruptive technologies, innovation, life sciences

The life sciences industry will be subject to major disruption from five key trends over the coming years, a report …

News
mobile apps

Number of mobile health apps quadruples in two years

September 18, 2015
Medical Communications apps, clinical trials, communications, digital, mhealth, technology

The number of mobile health applications available to consumers has reached more than 165,000, as the industry for sensors and …

News
BIS

UK second in global innovation index

September 18, 2015
Medical Communications, Research and Development Global Innovation Index, World Intellectual Property Organisation, innovation, intellectual property, patents, wipo

The UK – along with Switzerland, Sweden, the Netherlands and the US – is in the world’s five most innovative …

News
266812

Jamie McGarvey joins Astellas Pharma communications team

September 18, 2015
Medical Communications Astellas, Astellas Pharma, Jamie McGarvey

Astellas Pharma has appointed Jamie McGarvey as senior manager of employee communications within its corporate affairs department.  McGarvey will be …

Appointment
BioInject

Sandoz opens €150m manufacturing facility

September 18, 2015
Manufacturing and Production Austria, BioInject, Novartis, Sandoz

Sandoz has opened a €150m state-of-the-art biopharmaceutical manufacturing facility in Schaftenau, Austria.  Known as BioInject will result in the creation …

News
AstraZeneca_drug_discovery

AstraZeneca and US Government collaborate to develop new antibiotics

September 17, 2015
Research and Development AstraZeneca, Azactam, BARDA, Department of Health and Human Services, HHHS, avibactam, aztreonam

AstraZeneca has entered into a public-private partnership with the US Department of Health and Human Services to develop drugs to …

News
eugene_van_rensburg-astellas

Astellas Pharma EMEA appoints new chief financial officer

September 17, 2015
Sales and Marketing Astellas, Eugene Van Rensburg

Astellas Pharma Europe, Middle East and Africa has appointed Eugene Van Rensburg to the position of chief financial officer, from …

Appointment
Abraxane

NICE says Celgene’s Abraxane is ‘too expensive for pancreatic cancer’

September 17, 2015
Sales and Marketing Abraxane, Celgene, NICE, Pancreatic cancer

NICE has decided not to recommend Abraxane (nab-paclitaxel) by Celgene in combination with gemcitabine for adults with metastatic pancreatic cancer.In …

News
ABPI

PMPCA rules on multiple pharma code breaches

September 17, 2015
Medical Communications, Sales and Marketing ABPI, ABPI Code, PMCPA, Prescriptions Medicine Code of Practice Authority

The industry’s code of conduct regulator has ruled on several alleged breaches of the ABPI code of pharmaceutical conduct by …

News
avastin_24

Cancer Drugs Fund ‘not sustainable in current form’

September 17, 2015
CDF, Cancer Drugs Fund, Department of Health, NHS England, National Audit Office, Public Accounts Committe, Roche, avastin

The Cancer Drugs Fund has improved access to treatments, although the UK still lags behind other countries despite its ‘unsustainable’ …

News
Amgen

Amgen joins M&A rush with deals for Dezima and Xencor

September 16, 2015
Research and Development, Sales and Marketing Amgen, Cancer, Denzime, Xencor, cardiovascular disease, high cholesterol, inflammation

Amgen has struck deals that could potentially be worth $3.25 billion, to purchase the Dutch firm Dezima and kick-off a …

News
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026